Forte Biosciences, Inc.
FBRX
$17.00
$1.338.49%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -22.14M | -24.79M | -17.68M | -11.25M | -15.66M |
| Total Depreciation and Amortization | 19.00K | 19.00K | 17.00K | 15.00K | 13.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.17M | 1.67M | 1.47M | 1.50M | 1.38M |
| Change in Net Operating Assets | 139.00K | 6.63M | 2.19M | -322.00K | 3.91M |
| Cash from Operations | -18.81M | -16.47M | -14.00M | -10.06M | -10.36M |
| Capital Expenditure | -- | 0.00 | -55.00K | 0.00 | -61.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 0.00 | 0.00 | 36.35M |
| Cash from Investing | -- | 0.00 | -55.00K | 0.00 | 36.29M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 101.00K | 15.00K | 1.81M | 75.00M | 9.00K |
| Repurchase of Common Stock | -27.00K | -6.00K | -5.00K | -3.00K | -15.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -475.00K | -4.65M | -2.32M |
| Cash from Financing | 74.00K | 9.00K | 1.33M | 70.35M | -2.32M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.73M | -16.46M | -12.73M | 60.29M | 23.61M |